Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bayzed Health GroupHKSE:02609 +0.90%12 Return-on-Tangible-Asset is 1.71% as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Bayzed Health Group ranks worse than 54.88% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Bayzed Health Group's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$32 Mil. Bayzed Health Group's average total tangible assets for the quarter that ended in Dec. 2025 was HK$1,894 Mil. Therefore, Bayzed Health Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 1.71%.
The historical rank and industry rank for Bayzed Health Group's Return-on-Tangible-Asset or its related term are showing as below:
HKSE:02609'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -5 Med: -2.1 Max: 1.73
Current: 1.73
During the past 5 years, Bayzed Health Group's highest Return-on-Tangible-Asset was 1.73%. The lowest was -5.00%. And the median was -2.10%.
HKSE:02609's Return-on-Tangible-Asset is ranked worse than 54.88% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs HKSE:02609: 1.73
Bayzed Health Group (HKSE:02609) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Bayzed Health Group Return-on-Tangible-Asset Related Terms
Bayzed Health Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Bayzed Health Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayzed Health Group Return-on-Tangible-Asset Chart
HKSE:02609 vs HCA, THC, EHC: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Bayzed Health Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayzed Health Group Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bayzed Health Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Bayzed Health Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 1.71% mean?
Bayzed Health Group (HKSE:02609) has a Return-on-Tangible-Asset of 1.71% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bayzed Health Group and its competitors. According to the industry distribution chart, Bayzed Health Group ranks #377 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 54.9%.
Is Bayzed Health Group's Return-on-Tangible-Asset too high?
Bayzed Health Group's current Return-on-Tangible-Asset is 1.71%. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. Bayzed Health Group's value of 1.71% is 34% below this industry median. Based on the distribution chart, Bayzed Health Group ranks #377 out of 687 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bayzed Health Group ranks #377 out of 687 companies for Return-on-Tangible-Asset. This places Bayzed Health Group in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.59. Bayzed Health Group's value of 1.71% is 34% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayzed Health Group's current Return-on-Tangible-Asset of 1.71% is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bayzed Health Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayzed Health Group's current Return-on-Tangible-Asset is 1.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current Return-on-Tangible-Asset of 1.71%. The current Return-on-Tangible-Asset is 1.71% and 34% below the Healthcare Providers & Services industry median of 2.59. Bayzed Health Group's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current Return-on-Tangible-Asset is 1.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score
Get the complete analysis for HKSE:02609
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02609 has been successfully added to your 
